Re: snippets
3rd flu-meeting in Münster 2012.09.02
201 pages .pdf , 131 flu-research abstracts
3rd flu-meeting in Münster 2012.09.02
201 pages .pdf , 131 flu-research abstracts
Code:
P1 Dengue Virus Coinfection Exacerbates Influenza Replication Benjamin Bradley1, Mei-Chun Chen1, Gena Nichols1, Somanna Naveen1, Gregor Manukian, Catherine Arnold1, Courtney Standlee1, Jackson Voss1, Alex LaVanway1, Kayleigh Voss1, Courtney Garry1, Thomas V* P2 Avian influenza viruses inhibit the major cellular signaling integrator c-Abl Eike R. Hrincius , Swantje Liedmann , Darisuren Anhlan , Thorsten Wolff , Stephan Ludwig and Christina Ehrhardt* P3 Broadly protective trivalent recombinant heterologous influenza H5N1 challenge M. Prabakaran* P4 Modeling influenza virus replication on a single cell level T. Frensing* P5 Single mutations in HA and NP mediate enhanced pathogenicity of 2009 H1N1 pandemic influenza virus in mice A. Otte* P6 Host serine proteases mediate differential cleavage of HA of different H1N1-PR8 variants Mahmoud M. Bahgat* P7 The influenza virus PB1-F2 protein has interferon-antagonistic activity S. E. Dudek* P8 Tracking influenza virus fusion ­ Relation between endosomal pH and stability of the influenza hemagglutinin C. Mair1* P9 Human-like PB2 627K influenza virus polymerase activity is regulated by importin-1 and -7 Ben Hudjetz* P10 Adaptation of influenza vaccine donor strain in Vero cells results in elevated viral polymerase activity Ke Xu* P11 Comparative immunological investigations in mice after infection with mouseadapted variants of a classical H1N1 Swine Influenzavirus and the pandemic H1N1/2009 Influenzavirus J. Bogs* P12 Rps6 phosphorylation is required for efficient Influenza infection C. Carron1, O. Terrier1, G. Therizols2, B. Panthu3, G. Cartet1, A. Traversier1, F. Janaud1, S. Hacot2, B. Lina1, T. Ohlmann3, S. Ludwig4, J-J. Diaz2, M. Rosa-Calatrava1* P13 Influenza A viruses control the expression of pro-viral human p53 isoforms, p53 and 133p53 in human lung epithelial cells O. Terrier1* P14 Differential effects of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells M. Michaelis1* P15 A novel single-virus infection system reveals that influenza virus preferentially infects resting cells Ayae Honda1,Tadao Sugiura2, Fumihito Arai3 1.Hosei University, Tokyo , Japan, 2. Nara Institute of Science and Technology, Nara, Japan, 3. Nagoya Univ* P16 Isolation and characterization of H9N2 avian influenza virus from Bangladesh R. Parvin* P17 Role of the amphiphilic helix of M2 and the cytoplasmic tail of HA for virus budding M. Veit1* P18 Prior vaccination with livevirus protects highly susceptible DBA/2J mice from lethal influenza A H1N1 infection Leonie Dengler* P19 Pseudotyped Newcastle Disease Virus with Paramyxovirus 8 Surface Glycoproteins and Highly Pathogenic Avian Influenza Virus Hemagglutinin Steglich C.1* P20 Molecular and immunological characterisation of influenza A(H1N1)pdm09 viruses N. Ikonen, M. Strengell, M. Haanpää, T. Ziegler and I. Julkunen* P21 Proteolytic cleavage of influenza A H1N1 hemagglutinin is strongly impaired in Tm prss2 deficient mice Bastian Hatesuer1* P22 Studies on the inhibitory activity of influenza virus-specific neuraminidase inhibitors (NAI) against Pseudom onas aeruginosa C. Leitzinger1* P23 Evolution of German swine influenza A viruses - a progress report J.Lange1* P24 Introduction of adaptive mutations in the PB2-subunit of A/Hamburg/05/2009 (H1N1) increase the in vitro polymerase activity and in vivo pathogenicity in the C57BL/6 mouse model Folker Schwalm1* P25 Modulation of the Type I Interferon System by -Catenin upon Influenza A Virus Infection A. Hillesheim* P26 Critical role of segment-specific genome reassortment of influenza A viruses in vitro. packaging signals in genetic* P27 Cross-Protection between human and European swine H3N2 influenza viruses Yu Qiu* P28 Ribavirin but not oseltamivir should be used as control compound in efficacy studies of new anti-influenzaviral compounds against pandemic H1N1 influenza virus (pH1N1) in mice N. Seidel1* P29 Investigation of the efficacy of Tamiflu® against avH1N1 and huH1N2 swine influenza viruses in pigs R. Dürrwald1* P30 Matriptase activates the hemagglutinin of H9N2 influenza A viruses from Asia Joanna Baron1, Carolin Tarnow1, Deborah M. Nüssle1, Daniela Meyer2, Torsten Steinmetzer2, Wolfgang Garten1, Hans-Dieter Klenk1, Eva Böttcher-Friebertshäuser1* P31 Influenza virus binds its host cell using multiple dynamic interactions revealed by Single Virus Force Spectroscopy and Force Probe MD C. Sieben1* P32 Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and Respiratory Synctial Virus Viktoria Stab1, Sandra Nitsche1, Thomas Niezold1, Michael Storcksdieck genannt Bonsmann1, Andrea Thomas1, Bettina Tippler1, Chris* P33 Characterization of egg-culture derived, neuraminidase-negative variants of highly pathogenic avian influenza virus H5N1 Donata Kalthoff* P34 No Apparent Constraints for Novel H3 HA Reassortants with Pandemic Potential A. Kreibich1, O. Stech1, J. Hundt1, 2, T. C. Mettenleiter1, and J. Stech1* P35 Genotypical and phenotypical analysis of two influenza A PR8 variants reveal type I IFN antagonistic properties of influenza polymerase proteins Swantje Liedmann1* P36 Influenza A virus entry into cells lacking sialylated N-glycans Erik de Vries* P37 Comparative analysis of some biological properties of influenza (1N1)pdm09 virus strains isolated in Russia in 2009 and 2011 Prokopeva E.A.1,2,* P38 Bcl-2 proteins are central components of host immunity L. Kakkola, O. Denisova, D. Kainov* P39 MAPKAPK 3 inhibits IFN gamma secretion after flu infection and cytokine stimulation K. Koether11* P40 A reverse genetics approach to study the determinants for dsRNA-binding and PKR inhibition of the influenza A virus NS1 protein K.L. Schierhorn1* P41 The inhibition of human cytokines by small molecules such as RV1088 in response to influenza virus infections of primary respiratory cell cultures J. Ashcroft1* P42 Innate resistance of pig cells against highly pathogenic avian influenza (HPAI) H5N1 virus infection is associated with reduced pro-inflammation and infectious virus release. Rahul K. Nelli1* P43 The importin-7 gene is a determinant of viral cell tropism in the murine lung P. Resa-Infante1* P44 Inhibition of cellular MAP kinase p38 impairs influenza virus induced primary and secondary host gene responses and protects mice from lethal H5N1 infection Börgeling, Y.1* P45 Decreased activity of avian-like influenza polymerase in human cells is independent of the viral nucleoprotein Duncan Paterson* P46 Avian and Human Influenza Virus Surveillance in Asian part of Russia (20102011) Silko N.Yu.* P47 Evaluation of antiviral activity of SALPs against influenza viruses Julia Hoffmann* P48 The influenza virus and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in the human respiratory and gastrointestinal tracts S. Bertram1* P49 Influenza A virus nucleoprotein targets specific subnuclear domains Chris T. Hoefer 1* P50 Cloning, Expression, and Characterization of Ferret Genes G. Manukian1, S. Naveen1, BS Kaplan2, TG Voss1* P51 Antiviral defense mechanisms in alveolar type II epithelial cells are altered in chronically diseased lungs and counteract with influenza A infection Marcus Gereke1,2* P52 Early protection of balb/c mice against lethal HPAIV H5N1 challenge infection Susanne Röhrs* P53 Influenza virus tropism in human and swine respiratory tract Renee WY Chan1,2* P54 A systems-based approach to examine the host response in permissive cells types infected with Low Pathogenic Avian Influenza Viruses and low passage human clinical influenza pH1N1 isolates. Richard Sutejo1, Dawn S. Yeo1,2, Myint Zu Myaing1,Chen Hui1 ,Jia* P55 Activation of the Rar-related orphan receptor alpha by H5N1 leads to subsequent NF-B inhibition and suppression of inflammatory responses in monocytes J. Friesenhagen1,2* P56 A siRNA screen to detect influenza virus strain-specific differences in required host cell factors M. Lesch1* P57 Use of CaCo-2 cells for isolation of influenza virus from clinical and post mortem samples E. Bildanova* P58 Effect of influenza virus infection on gelatinases in human monolayer cell cultures D. Danilenko* P59 Acylation of influenza A virus M2 and HA might work synergistically for efficient budding of virus particles S. Siche1* P60 Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner H. Kollmus1* P61 Novel influenza antiviral agents O. Denisova* P62 Porcine airway epithelial cells provide a model system to study proteolytic activation of influenza A viruses C. Freuer* P63 A four-year survey of the oseltamivir-resistant influenza viruses in Ukraine L. Leibenko1* P64 Whole-genome transcriptome analysis of influenza-infected mouse lungs reveals the kinetics of the complex host response Esther Wilk1* P65 A network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus Catherine Isel1* P66 Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses Wolfgang Nacken* P67 Antiviral activity of some benzimidazole and spiroindolinpyrrolizidine derivatives against influenza A(H1N1) 2009 virus Liubov A. Karpinskaya1* P68 Pandemic A/H1N1 (2009) Swine Influenza Virus Detection and Isolation in Commercial Piggery, Lagos Nigeria Meseko, C.A1, 2* P69 Bimolecular fluorescence complementation oligomerisation of Mx Proteins Schilling Mirjam* P70 Model for the caspase-dependent nuclear RNP export in influenza virus-infected cells J. Dzieciolowski1* P71 A novel vector to clone influenza A viruses segments for the bi-directional, simultaneous generation of vRNA and mRNA using a CcdB selection marker and alternative cloning sites Ahmed Elsayed1* P72 Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase G. Muratore1, L. Goracci2, B. Mercorelli1, A. Foeglein3, P. Digard3,4, G. Cruciani2, G. Palù1, and A. Loregian1* P73 Possible factors influencing the influenza vaccine induced antibody response in the elderly B. Camilloni1, M. Basileo1, E. Lepri1, A. Cherubini2, G. Dell'Aquila2, P. Tozzi3, G. Bartolini 3, V. Committeri3, A. M. Iorio1* P74 Studies of the host response to influenza A virus infections in mouse knock-out mutants Mohamed A. Tantawy 1,2* P75 EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo Linda L. Theisen1* P76 Antiviral activity of Enterococcus faecium on the replication of Swine Influenza Virus in Vitro Zhenya Wang1* P77 Activity of synthetic peptide glutamyl-tryptophane in glycirrhizinic acid against lethal influenza on mouse model combination with* P78 Identification of Interferon stimulated genes in the chicken Susanne Röll1* P79 Shift of oxygen saturation in the blood of different mouse inbred strains after influenza A infection N. Mehnert1* P80 Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine. D. Anhlan1* P81 Shedding of resistant and susceptible influenza viruses in infants during oseltamivir treatment B.Rath2, M. von Kleist3, F. Tief2, K. Karsch2, E. Tuerk2, S. Muehlhans2, F. Louis4, H. Skopnik4, B. Schweiger1, S. Duwe1* P82 Growth Of Porcine Influenza Viruses In Differentiated Respiratory Epithelial Cells A. Fandan Meng1* P83 Experimental infection of Common gull (Larus canus) with H5N1 highly pathogenic avian influenza virus E. Sherstkov1,2* P84 Structure of humoral immune response to the pandemic (H1N1)pdm09 virus in vaccinated and unvaccinated patients A.A.Vasilyeva1* P85 Discrimination between 2-3- and 2-6-sialylated receptor gangliosides of influenza A virus using immunodetection combined with electrospray ionization mass spectrometry G. Pohlentz1* P86 Detection of antiviral-resistant influenza A(H1N1)pdm09 viruses in Japan by a combination of chemiluminescent and fluorescent neuraminidase inhibitor susceptibility assays E. Takashita1* P87 Induction of Apoptosis by Seasonal and Highly Pathogenic IAV in ex vivo infected Human Lung Tissue A. Becher1* P88 The significance of the influenza, ARI and SARI surveillance system in Republic of Moldova P.Scofera1, R.Cojocaru1* P89 The role of the FGF10/FGFR2b axis in epithelial repair following severe influenza pneumonia J. Quantius1* P90 Components of the human interactome of influenza A virus ribonucleoproteins revealed by RNA tagging and proteomics A. York1* P91 Contrasting regulation of suppressors of cytokine signalling (SOCS) between human and pig tracheal epithelial cells following highly pathogenic avian influenza virus infection A. Chang Pengxiang1* P92 Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptorRig-I to promote efficient type I interferon production Rüdiger Dierkes* P93 Comparison of data of Influenza Routine vs. Sentinel Surveillance System in Georgia, influenza seasons 2009-2010/2010-2011 O. Tarkhan-Mouravi1* P94 The human Mx locus exhibits potent antiviral activity in an inducible transgenic mouse model C. Deeg1* P95 The Combined Action of Influenza Virus and Staphylococcus aureus PantonValentine Leukocidin Provokes Severe Lung Epithelium Damage S. Niemann1,3* P96 Polymerase mutations promoting adaptation of avian influenza virus of subtype H9N2 to mammals. Hanna Sediri1* P97 Newly designed furin-specific inhibitors exhibit potent inhibitory efficacy against highly pathogenic influenza viruses Yinghui Lu1* P98 Host-specific differences in membrane fusion activity of influenza A viruses J. Baumann1* P99 Antiviral activity of chicken interferon- in chickens A. Reuter1,4, D. Rubbenstroth1, S.M. Soubies1* P100 Influenza A NS1 protein is required for efficient segment 7 mRNA nuclear export C. Pereira1* P101 Identification of interferon- producing cells in influenza A virus-infected mouse lungs C.Kallfass1* P102 Influenza-virus infection impacts on alveolar edema clearance: role of virus- and host factors in regulation of alveolar epithelial cell ENaC and Na,K-ATPase expression C.Becker1* P103 Alteration of infectivity and antigenicity by host adaptation of the first Japanese A/H1N1pdm09 isolate Hideki Asanuma1,2* P104 Comparative analysis of mammalian ganglioside receptors of influenza A viruses and soluble hemagglutinins A. Hucke1, D. Eberhardt1, G. Pohlentz1, A.-K. Sauer2, G. Herrler2, C. Ehrhardt3, S. Ludwig3, W. Storck1, I. Meisen1, M. Mormann4, H. Karch1, J. Müth* P105 Using quantitative proteomic analysis of recombinant influenza A virus to define the interactome of the viral NS1 protein in human lung cells K. Paki1, T. Schwecke2, A. Sadewasser1, T. Wolff1* P106 Sialyl Lewisx gangliosides: novel receptors of human H3N2 influenza A viruses I. Meisen1,2* P107 Pigs as an intermediate host for the adaptation of Asian lineage H5N1 highly pathogenic avian influenza (HPAI) viruses to mammals Brandon Z. Londt* P108 Macrophage-expressed IFN- mediates apoptotic alveolar epithelial injury in severe influenza virus pneumonia Katrin Högner* P109 Anti-influenza virus activity of nucleoside inhibitors of the influenza virus polymerase E. Vanderlinden1* P110 Mutations in the cytoplasmic tail of HA in Influenza virus ­ with focus on SAcylation Katharina Brett* P111 Antigenic variation of H2N2 influenza viruses during 11 years of evolution Martin Linster1* P112 P38 MAPK signaling pathway is involved in regulating interferon-1-mediated immune responses after RNA stimulation Miao Jiang1,2,3* P113 Hemadsorption activity of the neuraminidase of H1N1/09 pandemic influenza virus and its swine precursors V. Czudai-Matwich1* P114 Emergence of novel influenza A(H3N2) variants in Germany during 2011-2012 M. Wedde1* P115 Specific amino acid in NS1 of highly pathogenic avian influenza A viruses effect the viral replication in mammalian cell. Pumaree Kanrai* P116 Influenza virus infection of dendritic cells interferes with the immune response Annette B. Vogel1* P117 Characterization of 7:1 gene reassortants of H1N1/09 pandemic influenza virus containing different N1 neuraminidases T. Gerlach1* P118 MAT1 and epitheliasin are HA-activating proteases of the influenza mouse model C. Tarnow1* P119 Data Curation of the GISAID EpiFlu Influenza Database Anne Pohlmann1* P120 Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein Dornfeld D.1* P121 Elucidating the role of nucleoprotein in influenza A virus replication and transcription L. Turrell* P122 Cytokine expression at different stages of infection of A(H1N1)pdm09 in porcine lung using laser capture microdissection D. Hicks, A. Orlowska, M. Kelly, B. Londt* P123 Promoter binding studies of the influenza A RNA polymerase N.C. Robb1* P124 Novel antiviral drug ingavirinR restores the cellular antiviral response in influenza A virus infection and enhances viral clearance in ferrets Irina Kuznetsova 1, Andrei Egorov 1, Thomas Aschacher 1, Vladimir Nibolsin 2, Michael Bergmann* P125 H5N1 virus in Russia (2005-2011): molecular epidemiology, ecology and evolution Alexander Shestopalov* P126 Analysis of the receptor binding properties of influenza A hemagglutinins using soluble chimeric proteins Anne-Kathrin Sauer1* P127 Identification of cellular proteins interacting with influenza A virus polymerase using a virus-based split-luciferase complementation assay C. Chiang1* P128 Human importin-7 increases the half-life of the influenza virus polymerase subunit PB2 S. Thiele1* P129 A novel optical microscopy approach to characterize size and morphology of single influenza virus particles E.C. Plötz1, D.W. Siegersma1, A.M. van Oijen1, E. Fodor2, N.C. Robb2, & T. Cordes1 P130 Annexin A6 is a novel host factor in influenza A virus infection A. Musiol1* P131 A novel vector to clone influenza A viruses segments for the bi-directional, simultaneous generation of vRNA and mRNA using a CcdB selection marker and alternative cloning sites Ahmed Mostafa1*
Comment